NASDAQ: ARTL
Artelo Biosciences Inc Stock Ownership - Who owns Artelo Biosciences?

Insider buying vs selling

Have Artelo Biosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARTL insiders and whales buy or sell their stock.

ARTL Shareholders

What type of owners hold Artelo Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter Michael Obrien10.51%345,000$348.45kInsider
Gregory D. Gorgas8.32%273,076$275.81kInsider
John Joseph Crawford2.92%95,671$96.63kInsider
Sharon M. Oster1.90%62,373$63.00kInsider
Connie Matsui1.73%56,667$57.23kInsider
Geode Capital Management LLC0.53%17,350$17.52kInstitution
Ubs Group Ag0.41%13,297$13.43kInstitution
Tower Research Capital LLC Trc0.12%3,818$3.86kInstitution
Geneve Corp0.03%1,013$1.02kInsider
Bank Of America Corp0.00%26$26.26Institution

1 of 3

ARTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTL1.05%25.41%
PALI2.35%97.65%Net Selling
SNPX1.05%19.36%
TTNP0.01%99.99%
MTNB1.11%98.89%

Artelo Biosciences Stock Ownership FAQ

Who owns Artelo Biosciences?

Artelo Biosciences (NASDAQ: ARTL) is owned by 1.05% institutional shareholders, 25.41% Artelo Biosciences insiders, and 73.54% retail investors. Peter Michael Obrien is the largest individual Artelo Biosciences shareholder, owning 345,000.00 shares representing 10.51% of the company. Peter Michael Obrien's Artelo Biosciences shares are currently valued at $348.45k.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.